NewAmsterdam Pharma
NAMS
NAMS
32 hedge funds and large institutions have $692M invested in NewAmsterdam Pharma in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
9% less funds holding
Funds holding: 35 → 32 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
32
Holding in Top 10
4
Calls
$13.4M
Puts
–
Top Buyers
| 1 | +$15.5M | |
| 2 | +$3.14M | |
| 3 | +$2.96M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.12M |
| 5 |
Morgan Stanley
New York
|
+$619K |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$3.97M | |
| 3 | -$3.2M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$2.75M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$416K |